Romuald Zdrojowy

Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival

Steffen Walter, Toni Weinschenk, Arnulf Stenzl et al. · Nature Medicine · 2012 · 784 citations

Medicine, Immunology, Oncology +17

A large germline deletion in the Chek2 kinase gene is associated with an increased risk of prostate cancer

Cezary Cybulski, Dominika Wokołorczyk, Tomasz Huzarski et al. · Journal of Medical Genetics · 2006 · 115 citations · Full text

Life Sciences, Genetics, Molecular Genetics +15

An inherited NBN mutation is associated with poor prognosis prostate cancer

Cezary Cybulski, Dominika Wokołorczyk, Wojciech Kluźniak et al. · British Journal of Cancer · 2012 · 99 citations · Full text

Life Sciences, Genetics, Oncology +17

Efficacy and Safety of Autologous Dendritic Cell–Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With Metastatic Castration-Resistant Prostate Cancer

Nicholas J. Vogelzang, Tomasz M. Beer, Winald R. Gerritsen et al. · JAMA Oncology · 2022 · 90 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Durvalumab in combination with BCG for BCG-naive, high-risk, non-muscle-invasive bladder cancer (POTOMAC): final analysis of a randomised, open-label, phase 3 trial

Maria De Santis, Joan Palou Redorta, Hiroyuki Nishiyama et al. · The Lancet · 2025 · 47 citations · Full text

Medicine, Oncology, Urology +13